TP53 and neoplasm: Another important anti-tumour activity of peptides with anticancer activity (known as anticancer peptides—ACPs) may involve cell cycle arrest through interactions with key regulatory proteins such as p53, a transcription factor essential for maintaining genome integrity, whose mutations are frequently associated with uncontrolled cell proliferation and tumour progression [53].